Early disruption of the bloodbrain barrier after thrombolytic therapy predicts hemorrhage in patients with acute stroke

Stroke

Volumn 39, Issue 8, 2008, Pages 2385-2387

  Kastrup, Andreas ^a,b   Gröschel, Klaus ^a,b   Ringer, Thomas M ^b   Redecker, Christoph ^b   Cordesmeyer, Robert ^a   Witte, Otto W ^b   Terborg, Christoph ^b  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

^b FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

Author keywords

Hemorrhage; Magnetic resonance imaging; Thrombolytic therapy

Indexed keywords

ALTEPLASE; GADOLINIUM; DIAGNOSTIC AGENT; FIBRINOLYTIC AGENT; TISSUE PLASMINOGEN ACTIVATOR;

ADULT; AGED; ARTICLE; BLOOD BRAIN BARRIER; BLOOD CLOT LYSIS; BRAIN HEMORRHAGE; BRAIN INFARCTION; CONTRAST ENHANCEMENT; DETERIORATION; DIFFUSION WEIGHTED IMAGING; DISEASE ASSOCIATION; FEMALE; FIBRINOLYTIC THERAPY; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; NUCLEAR MAGNETIC RESONANCE IMAGING; PERFUSION WEIGHTED IMAGING; PRIORITY JOURNAL; RETROSPECTIVE STUDY; STROKE; STROKE PATIENT; ACUTE DISEASE; DRUG EFFECT; FACTUAL DATABASE; INCIDENCE; INTRAVENOUS DRUG ADMINISTRATION; LETTER; MIDDLE AGED; PATHOLOGY; PREDICTION AND FORECASTING; RISK FACTOR;

ACUTE DISEASE; AGED; AGED, 80 AND OVER; BLOOD-BRAIN BARRIER; CEREBRAL HEMORRHAGE; DATABASES, FACTUAL; DIFFUSION MAGNETIC RESONANCE IMAGING; FEMALE; FIBRINOLYTIC AGENTS; GADOLINIUM; HUMANS; INCIDENCE; INJECTIONS, INTRAVENOUS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES; RISK FACTORS; STROKE; THROMBOLYTIC THERAPY; TISSUE PLASMINOGEN ACTIVATOR;

EID: 49849089117     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/STROKEAHA.107.505420     Document Type: Article

References (9)

1. Larrue V, von Kummer RR, Muller A, Bluhmki E. Risk factors for severe hemorrhagic transformation in ischemic stroke patients treated with recom-binant tissue plasminogen activator: a secondary analysis of the European-Australasian Acute Stroke Study (ECASS II). Stroke. 2001;32: 438-441.
2. Tanne D, Kasner SE, Demchuk AM, Koren-Morag N, Hanson S, Grond M, Levine SR. Markers of increased risk of intracerebral hemorrhage after intravenous recombinant tissue plasminogen activator therapy for acute ischemic stroke in clinical practice: the Multicenter rt-PA Stroke Survey. Circulation. 2002;105:1679-1685.
3. Dijkhuizen RM, Asahi M, Wu O, Rosen BR, Lo EH. Rapid breakdown of microvascular barriers and subsequent hemorrhagic transformation after delayed recombinant tissue plasminogen activator treatment in a rat embolic stroke model. Stroke. 2002;33:2100-2104.
4. Neumann-Haefelin C, Brinker G, Uhlenkuken U, Pillekamp F, Hossmann KA, Hoehn M. Prediction of hemorrhagic transformation after thrombolytic therapy of clot embolism: an MRI investigation in rat brain. Stroke. 2002;33:1392-1398.
5. Kim EY, Na DG, Kim SS, Lee KH, Ryoo JW, Kim HK. Prediction of hemorrhagic transformation in acute ischemic stroke: role of diffusion-weighted imaging and early parenchymal enhancement. AJNR Am J Neu-roradiol. 2005;26:1050-1055.
6. Vo KD, Santiago F, Lin W, Hsu CY, Lee Y, Lee JM. MR imaging enhancement patterns as predictors of hemorrhagic transformation in acute ischemic stroke. AJNR Am J Neuroradiol. 2003;24:674-679.
7. Latour LL, Kang DW, Ezzeddine MA, Chalela JA, Warach S. Early blood- brain barrier disruption in human focal brain ischemia. Ann Neurol. 2004;56:468-477.
8. Thomalla G, Sobesky J, Kohrmann M, Fiebach JB, Fiehler J, Zaro WO, Kucinski T, Juettler E, Ringleb PA, Zeumer H, Weiller C, Hacke W, Schellinger PD, Röther J. Two tales: hemorrhagic transformation but not parenchymal hemorrhage after thrombolysis is related to severity and duration of ischemia: MRI study of acute stroke patients treated with intravenous tissue plasminogen activator within 6 hours. Stroke. 2007;38: 313-318.
9. Lansberg MG, Thijs VN, Bammer R, Kemp S, Wijman CA, Marks MP, Albers GW. Risk factors of symptomatic intracerebral hemorrhage after tPA therapy for acute stroke. Stroke. 2007;38:2275-2278.